BIETTI CRYSTALLINE DYSTROPHY
Clinical trials for BIETTI CRYSTALLINE DYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new BIETTI CRYSTALLINE DYSTROPHY trials appear
Sign up with your email to follow new studies for BIETTI CRYSTALLINE DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy trial aims to halt rare eye disease that steals sight
Disease control OngoingThis phase 3 study tests a gene therapy called VGR-R01 for people with Bietti Crystalline Dystrophy, a rare inherited eye disease that causes vision loss. The trial will enroll 45 adults to see if the treatment improves eyesight compared to no treatment. The goal is to control th…
Matched conditions: BIETTI CRYSTALLINE DYSTROPHY
Phase: PHASE3 • Sponsor: Shanghai Vitalgen BioPharma Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 11:32 UTC
-
Gene therapy trial offers hope for rare blinding disease
Disease control OngoingThis early-stage study tests a gene therapy called VGR-R01 in 12 adults with Bietti Crystalline Dystrophy, a rare inherited eye disease that causes vision loss. The main goal is to check if the treatment is safe and tolerable. Researchers will monitor side effects and changes in …
Matched conditions: BIETTI CRYSTALLINE DYSTROPHY
Phase: PHASE1 • Sponsor: Shanghai Vitalgen BioPharma Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 11:09 UTC